Latest Drugs, Latest Approval in Recombinant human erythropoietins

What are Recombinant human erythropoietins?

Recombinant human erythropoietins, act like endogenous erythropoietin to stimulate erythropoiesis, the process of red blood cell production. Endogenous erythropoietin is a hormone that is secreted by particular cells in the kidneys in response to reduced levels of oxygen reaching the tissues in the kidneys.

Recombinant human erythropoietins are given to patients with kidney failure to treat anemia.

Name Updated
Epoetin beta and methoxy polyethylene glycol (Epoetin beta and methoxy polyethylene glycol [ e-poe-e-tin-bay-ta-meth-ox-ee-pol-ee-eth-il-een-glye-kol ]) 16-Aug-2023
Epoetin alfa (Epoetin alfa [ e-poe-e-tin-al-fa ]) 16-Aug-2023
Darbepoetin alfa (Darbepoetin alfa [ dar-be-poe-e-tin-al-fa ]) 14-Aug-2023
Procrit (Epoetin alfa [ e-poe-e-tin-al-fa ]) 14-Jul-2023
Omontys (Peginesatide [ peg-in-es-a-tide ]) 13-Jul-2023
Mircera (Epoetin beta and methoxy polyethylene glycol [ e-poe-e-tin-bay-ta-meth-ox-ee-pol-ee-eth-il-een-glye-kol ]) 13-Jul-2023
Epogen (Epoetin alfa [ e-poe-e-tin-al-fa ]) 13-Jul-2023
Aranesp (Darbepoetin alfa [ dar-be-poe-e-tin-al-fa ]) 12-Jul-2023
Retacrit (Epoetin alfa [ e-poe-e-tin-al-fa ]) 11-Jul-2023